Becker's Hospital Review

March 2021 Issue of Becker's Hospital Review

Issue link: https://beckershealthcare.uberflip.com/i/1341133

Contents of this Issue

Navigation

Page 22 of 63

23 WOMEN'S LEADERSHIP 23 CEO / STRATEGY 4 leadership changes CEOs made during the pandemic By Iain Carlos M any CEOs have altered their lead- ership strategy in four crucial ways that led to positive changes at their organizations during the pandemic, though it's unclear whether those changes will remain aer COVID-19 has subsided, according to a McKinsey & Co. article. Here are the four leadership changes made, based on conversations with hundreds of CEOs during the pandemic: 1. Aspire 10 times higher. Leaders are real- izing that barriers to company goals are oen less about technical limits and more about a limited mindset, along with inefficient deci- sion-making and use of time. 2. Elevate "to be" to the same level as "to do." CEOs are recognizing that leadership isn't just about business decisions, but about shoring up team members' morale and inspiring a good workplace culture. 3. Fully embrace stakeholder capitalism. CEOs are understanding that they're obligated to company stakeholders, not just sharehold- ers, and must make company decisions on the basis of that obligation. 4. Harness the real power of peer networks. Many executives are speaking with other CEOs about making organizational decisions, both for the benefit of the company and for the sake of collaborating to take on larger is- sues like climate change and systemic racism. Many healthcare CEOs have embraced these leadership tenets during the pandemic. For example, Chris Van Gorder, president and CEO of San Diego-based Scripps Health, sent a memo to staff in March 2020 urging them to "be prepared, not frightened" of the novel coronavirus. In the summer, other healthcare CEOs sent memos to staff in response to pro- tests over racial disparities and excessive po- lice force that have occurred across the U.S. in the wake of George Floyd's death. e article ends by saying that society at large stands to benefit if CEOs maintain these changes permanently. n Tenet adds board member By Kelly Gooch D allas-based Tenet Healthcare has appointed Cecil Haney as a member of its board of directors, the for-profit hospital operator said Jan. 8. Mr. Haney is a U.S. Navy veteran, retiring as a four-star admiral. "Cecil has demonstrated the true tenets of servant leadership throughout his incredibly distinguished career in the U.S. military," Tenet Executive Chairman and CEO Ron Rittenmeyer said in a news release. "He is an extraordinary indi- vidual and leader who will complement our board, particularly in the areas of cybersecurity and systems planning." During his military career, Mr. Haney was commander of the U.S. Strategic Command and served as commander of the U.S. Pacific Fleet, Tenet said. He also held leadership roles in the submarine force and in joint assignments. Additionally, he served on the Military Leadership Diversity Commission. n After split with BJC HealthCare, Missouri hospital forms new management entity By Morgan Haefner C olumbia, Mo.-based Boone Hospital formed a new management entity as it moves forward with its break from St. Louis-based BJC HealthCare, according to local NBC affiliate KOMU. The entity, Boone Health, will manage operations for the hospital and its medical group, home care and hospice services. It will also manage the rela- tionships Boone Hospital has with area hospitals and private practice clinics. Boone Hospital is also expanding its board of trustees to create an 11-mem- ber governing board. Boone Hospital officially transfers to independent operations in April. The hospital's board decided to end its 30-year operating agreement with BJC HealthCare in 2018. n Moderna CEO says COVID is forever By Iain Carlos M oderna CEO Stephane Bancel said Jan. 13 that COVID-19 will be around forever, CNBC reported. Mr. Bancel's remark echoes warnings from public health officials and infectious disease experts that COVID-19 will become an endemic dis- ease, according to CNBC. An analysis published Jan. 12 in Science said that once COVID-19 becomes endemic, it may be no more virulent than the common cold. Mr. Bancel added that health officials will need to watch for new variants of the virus to produce new vaccines effective against them, wrote CNBC. "SARS-CoV-2 is not going away," Mr. Bancel said during a panel discussion at the JPMorgan Healthcare Conference, according to CNBC. n

Articles in this issue

view archives of Becker's Hospital Review - March 2021 Issue of Becker's Hospital Review